NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Ryon Graf
Foundation Medicine Inc. - Cambridge / United States
Others
AD Scientific Index ID: 4465140
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Ryon Graf's MOST POPULAR ARTICLES
1-)
Association of AR-V7 on circulating tumor cells as a treatment-specific biomarker with outcomes and survival in castration-resistant prostate cancerHI Scher, D Lu, NA Schreiber, J Louw, RP Graf, HA Vargas, A Johnson, ...JAMA oncology 2 (11), 1441-1449, 20165782016
2-)
Assessment of the validity of nuclear-localized androgen receptor splice variant 7 in circulating tumor cells as a predictive biomarker for castration-resistant prostate cancerHI Scher, RP Graf, NA Schreiber, A Jayaram, E Winquist, B McLaughlin, ...JAMA oncology 4 (9), 1179-1186, 20181842018
3-)
Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: a …KA Autio, R Dreicer, J Anderson, JA Garcia, A Alva, LL Hart, MI Milowsky, ...JAMA oncology 4 (10), 1344-1351, 20181602018
4-)
Nuclear-specific AR-V7 protein localization is necessary to guide treatment selection in metastatic castration-resistant prostate cancerHI Scher, RP Graf, NA Schreiber, B McLaughlin, D Lu, J Louw, DC Danila, ...European urology 71 (6), 874-882, 20171812017
5-)
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancerK Boudadi, DL Suzman, V Anagnostou, W Fu, B Luber, H Wang, ...Oncotarget 9 (47), 28561, 20181532018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept